» Articles » PMID: 18835574

Naturally-occurring Human Serum Antibodies to Inner Core Lipopolysaccharide Epitopes of Neisseria Meningitidis Protect Against Invasive Meningococcal Disease Caused by Isolates Displaying Homologous Inner Core Structures

Overview
Journal Vaccine
Date 2008 Oct 7
PMID 18835574
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Sera from healthy infants (under 1 year old), toddlers (3-4 years) and adults (18-65 years) were assayed for their ability to bind to inner core (ic) lipopolysaccharide (LPS) epitopes of Neisseria meningitidis. Antibodies (Abs) reacting to inner core structures, including different substitutions of the first heptose (HepI) and second heptose (HepII) residues of the LPS backbone, truncated and fully extended LPS glycoforms, were detected and for each structure, these inner core antibodies showed an age-related pattern of acquisition. A novel column-based methodology was used to affinity purify IgG antibodies in which purified inner core LPS (derived from a mutant MC58) was covalently linked to Sepharose 4B. Comparison of reactivity before and after affinity purification of the pooled sera showed that the purified Abs bound to the surface of N. meningitidis organisms displaying truncated and extended LPS with a homologous inner core region, promoted the deposition of C3b, were opsonophagocytic in vitro and decreased bacteraemia when used to passively protect infants rats. In addition, the purified Abs were bactericidal in vitro against the mutant strain displaying truncated LPS with a homologous inner core region. These results demonstrate that naturally occurring serum human antibodies to N. meningitidis LPS can access inner core epitopes of encapsulated organisms with a fully extended LPS.

Citing Articles

Conjugation of Meningococcal Lipooligosaccharides Through Their Non-Reducing Terminus Results in Improved Induction a Protective Immune Response.

Mieszala M, Jennings H, Drab M, Gamian A Arch Immunol Ther Exp (Warsz). 2019; 67(4):237-248.

PMID: 31030218 PMC: 6597602. DOI: 10.1007/s00005-019-00542-9.


An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep2Kdo2.

Kong L, Vijayakrishnan B, Kowarik M, Park J, Zakharova A, Neiwert L Nat Chem. 2016; 8(3):242-9.

PMID: 26892556 DOI: 10.1038/nchem.2432.


Antibacterials: A sweet vaccine.

Bundle D Nat Chem. 2016; 8(3):201-2.

PMID: 26892546 DOI: 10.1038/nchem.2468.


Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model.

Lewis L, Vu D, Granoff D, Ram S Infect Immun. 2014; 82(6):2574-84.

PMID: 24686052 PMC: 4019150. DOI: 10.1128/IAI.01517-14.


Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.

Nagaputra J, Rollier C, Sadarangani M, Hoe J, Mehta O, Norheim G Clin Vaccine Immunol. 2013; 21(2):234-42.

PMID: 24351756 PMC: 3910940. DOI: 10.1128/CVI.00561-13.